HIV_A_354716 73..85

1Madda Walabu University, Goba Referral Hospital, Pharmacy Department, Bale Goba, Ethiopia; 2Madda Walabu University, Goba Referral Hospital, Nursing department, Bale Goba, Ethiopia; 3Madda Walabu University, Goba Referral Hospital, Public Health Department, Bale Goba, Ethiopia; 4Madda Walabu University, Goba Referral Hospital, Biomedical Department, Bale Goba, Ethiopia; 5Madda Walabu University, Goba Referral Hospital, Surgery Department, Bale Goba, Ethiopia

[1]  M. Melku,et al.  Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study , 2021, HIV/AIDS.

[2]  B. D. Workneh,et al.  Prevalence and Predictors of Virological Failure Among Adults Living with HIV in South Wollo Zone, Northeast Ethiopia: A Retrospective Cohort Study , 2020, HIV/AIDS.

[3]  Setegn Eshetie,et al.  Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia , 2020, AIDS Research and Therapy.

[4]  E. Negussie,et al.  Financial burden of HIV and TB among patients in Ethiopia: a cross-sectional survey , 2020, BMJ Open.

[5]  A. Misganaw,et al.  Progress towards the 2020 Fast Track HIV/AIDS reduction targets in Ethiopia comparing with neighboring countries and across ages; using Global Burden of Diseases 2017 data , 2020 .

[6]  S. W. Asgedom,et al.  Immunologic and Clinical Failure of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus within Two Years of Treatment , 2020, BioMed research international.

[7]  Fitsum Weldegebreal,et al.  Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia , 2020, SAGE open medicine.

[8]  D. Demsie,et al.  Antiretroviral treatment failure among HIV-positive adults taking first-line therapy and associated risk factors at Adigrat General hospital, Adigart, Ethiopia 2019: A cross sectional study , 2020 .

[9]  Tadesse Tolossa,et al.  Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study , 2019, BMC Infectious Diseases.

[10]  Muluneh Alene,et al.  Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis , 2019, Global Health Research and Policy.

[11]  Yadeta Dessie Bacha,et al.  Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia , 2019, BMC Public Health.

[12]  Habtemu Jarso,et al.  Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study , 2019, BMC Infectious Diseases.

[13]  S. Hebo,et al.  Predictors of Time to First Line Antiretroviral Treatment Failure among Adult Patients Living with HIV in Public Health Facilities of Arba Minch Town, Southern Ethiopia , 2019, Ethiopian journal of health sciences.

[14]  B. Tessema,et al.  Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia , 2018, BMC Immunology.

[15]  H. Gesesew,et al.  Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study , 2018, BMJ Open.

[16]  Araya Gebreyesus Wasihun,et al.  Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia , 2018, PloS one.

[17]  David P. Wilson,et al.  The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical Model , 2018, Open forum infectious diseases.

[18]  R. Wanyenze,et al.  Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015 , 2017, BMC Infectious Diseases.

[19]  D. Haile,et al.  Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia , 2016, PloS one.

[20]  M. Ayalew,et al.  First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia , 2016, HIV/AIDS.

[21]  R. Gross,et al.  Brief Report: Apparent Antiretroviral Overadherence by Pill Count is Associated With HIV Treatment Failure in Adolescents , 2016, Journal of acquired immune deficiency syndromes.

[22]  A. King,et al.  Predictors of antiretroviral therapy failure in an urban HIV/AIDS clinic in Addis Ababa, Ethiopia , 2016 .

[23]  N. Kumarasamy,et al.  Virological efficacy with first‐line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression , 2015, Tropical medicine & international health : TM & IH.

[24]  A. Tefera,et al.  Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study , 2015, BMC Immunology.

[25]  A. Kumie,et al.  Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, Ethiopia , 2015, The Pan African medical journal.

[26]  M. Coker,et al.  Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria , 2015 .

[27]  K. Yirdaw,et al.  Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia , 2015, PloS one.

[28]  Ning Wang,et al.  Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003–2014 , 2015, BMJ Open.

[29]  D. Mmbando,et al.  Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data , 2015, Tropical medicine & international health : TM & IH.

[30]  David P. Wilson,et al.  Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces , 2014, Sexually Transmitted Infections.

[31]  G. Rutherford,et al.  Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure , 2014, AIDS.

[32]  N. Taveira,et al.  Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique , 2013, PloS one.

[33]  J. Willig,et al.  [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru]. , 2013, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[34]  M. Arnedo,et al.  Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya , 2012, PloS one.

[35]  Beth Chaplin,et al.  Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Desta Kassa Misgena.  The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): does success bring further challenges? , 2011 .

[37]  C. Gilks,et al.  The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives. , 2009, American journal of clinical pathology.

[38]  Julio S. G. Montaner,et al.  A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. , 2006, The Journal of infectious diseases.

[39]  M. Chesney,et al.  Adherence to HIV combination therapy. , 2000, Social science & medicine.

[40]  G. Cordero.  [HIV infection]. , 1995, SIDAhora : un proyecto del Departamento de Publicaciones del PWA Coalition, NY.